Marissa N. Balak
Publications by Year
Research Areas
Tuberous Sclerosis Complex Research, Lung Cancer Treatments and Mutations, Cancer Mechanisms and Therapy, PI3K/AKT/mTOR signaling in cancer, Peptidase Inhibition and Analysis
Most-Cited Works
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors(2006)827 cited
- → Studying clonal dynamics in response to cancer therapy using high-complexity barcoding(2015)521 cited
- → Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas(2007)313 cited
- → Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma(2008)276 cited
- → Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors(2007)124 cited
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)
- → Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus(2015)79 cited
- → BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity(2017)25 cited
- → Enhanced Motor Function by Training in Spinal Cord Contused Rats Following Radiation Therapy(2009)22 cited